跳至主要内容
临床试验/NCT02258347
NCT02258347已完成不适用

Use of a High Intensity Focused Ultrasound (HIFU) in Patients With Non-malignant Thyroid Nodules.

Theraclion2 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2014年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Theraclion
入组人数
4
试验地点
2
主要终点
Evaluation of thyroid nodule's structure changes following HIFU therapy assessed by ultrasonography (US)

研究概览

简要总结

Use of a high intensity focused ultrasound (HIFU) in patients with non-malignant thyroid nodules.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patient 18 years or older.
  • Patient presenting with at least one thyroid nodule with no signs of malignancy:
  • Non suspect clinically and at ultrasonography imaging
  • Benign cytological diagnosis at fine-needle aspiration biopsy (FNAB) from the last 6 months
  • Normal serum calcitonin
  • No history of neck irradiation
  • Normal thyroid-stimulating hormone (TSH).
  • Targeted nodule accessible and eligible to HIFU
  • Absence of abnormal vocal cord mobility at laryngoscopy.
  • Nodule diameter ≥ 10mm measured by ultrasound.
  • Nodule volume inferior to 10 cc
  • Composition of the targeted nodule(s) : no more than 30% cystic

排除标准

  • Head and/or neck disease that prevents hyperextension of neck.
  • Known history of thyroid cancer or other neoplasias in the neck region.
  • History of neck irradiation.
  • Macrocalcification inducing a shadow in the thyroid significant enough to preclude the HIFU treatment
  • Posterior position of the nodule if the thickness of the nodule is <15mm
  • Pregnant or lactating woman
  • Any contraindication to the assigned analgesia/anaesthesia.

研究组 & 干预措施

Single arm

Experimental

干预措施: Echopulse (Device)

结局指标

主要结局

Evaluation of thyroid nodule's structure changes following HIFU therapy assessed by ultrasonography (US)

时间窗: Month 6 and Month 12

Evaluation of thyroid nodule's vascularisation changes following HIFU therapy assessed by ultrasonography (US)

时间窗: Month 6 and Month 12

Evaluation of thyroid nodule's volume changes following HIFU therapy assessed by ultrasonography (US)

时间窗: Month 6 and Month 12

次要结局

  • Number of subjects with adverse events as a measure of safety and tolerability(Day 1, Month 1, Month 3, Month 6 and Month 12)

研究者

发起方
Theraclion
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验